- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00965237
Multifocal Contact Lens Use in Previous Contact Lens Wearers With Near Vision Demands (GARM)
June 26, 2012 updated by: CIBA VISION
P/331/09/C: Multifocal Pilot Study: Refitting Drop Outs (GARM)
The purpose of this study is to evaluate the use of a multifocal contact lens in people who previously wore contact lenses but discontinued due to age-related, near vision demands.
Study Overview
Status
Completed
Conditions
Study Type
Interventional
Enrollment (Actual)
16
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Ontario
-
Waterloo, Ontario, Canada, N2L 3G1
- University of Waterloo Centre for Contact Lens Research
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- ADULT
- OLDER_ADULT
- CHILD
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- has discontinued contact lens wear primarily due to age-related, near vision demands
- requires a reading add of +0.50 to +1.75 D (inclusive) and is correctable to at least 6/9 monocular, distance and near with spectacle correction
- has had an ocular examination in the last 2 years
- Other protocol-defined inclusion/exclusion criteria may apply
Exclusion Criteria:
- has any ocular disease
- has more than a 2.00D prescription difference between eyes
- cannot be fit successfully with the study contact lenses
- has any systemic disease affecting ocular health
- is using any systemic or topical medications that may affect ocular health
- has undergone corneal refractive surgery
- Other protocol-defined inclusion/exclusion criteria may apply
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: CROSSOVER
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Other: Multifocal CL / Single vision CL + reading glasses
Lotrafilcon B multifocal contact lenses (CL) worn first, with lotrafilcon B single vision contact lenses (CL) and over-reader spectacles worn second.
Both contact lens products worn bilaterally on a daily wear basis; over-reader spectacles worn on an as-needed basis.
|
Commercially marketed, silicone hydrogel, multifocal contact lens for daily wear use
Commercially marketed, silicone hydrogel, single vision contact lens for daily wear use
Reading glasses worn over single vision contact lenses for near vision work on an as-needed basis
|
Other: Single vision CL + reading glasses / Multifocal CL
Lotrafilcon B single vision contact lenses (CL) and over-reader spectacles worn first, with lotrafilcon B multifocal contact lenses (CL) worn second.
Both contact lens products worn bilaterally on a daily wear basis; over-reader spectacles worn on an as-needed basis.
|
Commercially marketed, silicone hydrogel, multifocal contact lens for daily wear use
Commercially marketed, silicone hydrogel, single vision contact lens for daily wear use
Reading glasses worn over single vision contact lenses for near vision work on an as-needed basis
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Overall Satisfaction With the Lenses
Time Frame: 1 week of wear
|
Overall satisfaction with the lenses was interpreted by and assessed by the subject as a single, retrospective measurement of one week's wear time.
Overall satisfaction with the lenses was recorded on a questionnaire as a numerical rating on a scale of 1 to 100, with 1 being completely dissatisfied, and 100 being excellent, completely satisfied.
|
1 week of wear
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
August 1, 2009
Primary Completion (Actual)
December 1, 2009
Study Completion (Actual)
December 1, 2009
Study Registration Dates
First Submitted
August 24, 2009
First Submitted That Met QC Criteria
August 24, 2009
First Posted (Estimate)
August 25, 2009
Study Record Updates
Last Update Posted (Estimate)
July 10, 2012
Last Update Submitted That Met QC Criteria
June 26, 2012
Last Verified
January 1, 2012
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- P-368-C-101
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Presbyopia
-
Johnson & Johnson Vision Care, Inc.CompletedPresbyopia CorrectionUnited Kingdom
-
Bausch & Lomb IncorporatedCompletedMyopia and Hyperopia and PresbyopiaUnited States
-
Technolas Perfect Vision GmbHUnknownHyperopic PresbyopiaIreland
-
Lee, Steven, M.D.CompletedMyopia, | Hyperopia, | Astigmatism, | Presbyopia, | Eye Strain,
-
Allotex, Inc.RecruitingPresbyopiaCzechia, Ireland, Turkey, United Kingdom
-
Coopervision, Inc.Centre for Ocular Research & Education, CanadaRecruitingPresbyopiaUnited States, Canada
-
Optall VisionRecruiting
-
Ji Xing Pharmaceuticals (Shanghai) Co., Ltd.LENZ Therapeutics, IncCompleted
-
Allotex, Inc.TerminatedPresbyopiaBelgium, Ireland, United Kingdom
-
Coopervision, Inc.CORECompletedPresbyopiaUnited States, Canada
Clinical Trials on lotrafilcon B multifocal contact lens
-
CIBA VISIONCompleted
-
CIBA VISIONCompleted
-
CIBA VISIONCompleted
-
CIBA VISIONUniversity of WaterlooCompleted
-
Johnson & Johnson Vision Care, Inc.Visioncare Research Ltd.Completed